AACR-ROUND-UP: A Novel Drug Delivery System And More Liquid Biopsy Results Highlight New Orleans Meeting
Highlights from the American Association for Cancer Research (AACR) Annual Meeting on April 19 include an implantable microdevice for evaluating drug efficacy in treating breast cancer tumors, as well as the latest research and innovation in liquid biopsy testing.
You may also be interested in...
Device Debuts is a new regular feature highlighting Medtech Insight editors’ top picks of medical devices that have been commercialized for the first time in the last month. This edition features an innovative minimally invasive surgical stapler, a pain-free blood-collection device, a novel approach for collecting, and circulating tumor cells, a rapid fluid-infusion device for critically ill patients, and an EP-mapping and navigation system.
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies